Meet the Expert: Management of HCV infection in patients with HCC

 Liver tumours

West 4
Meet the Experts
12 April 2018 10:30 - 11:20

Questions for discussion: 
1) Are DAAs as effective as in subjects with cirrhosis:
a) in patients with untreated HCC?
b) in patients with «cured» HCC?
2) Does SVR increase survival?
3) Does SVR affect transplantability?
4) Does DAA increase or reduce the risk of de novo HCC or recurrent HCC?